Dongcheng Pharmaceutical Subsidiary Gets Nod to Add New Specification for Dalteparin Sodium Injection

MT Newswires Live12-10

Yantai Dongcheng Pharmaceutical (SHE:002675) subsidiary, Yantai Dongcheng Northern Pharmaceutical, received approval from China's National Medical Products Administration to add a new specification for dalteparin sodium injection, according to a Shenzhen bourse filing on Wednesday.

The new specification to be marketed is 0.2 ml: 5000 AXa IU. The drug currently has a specification of 0.3 ml: 7500 AXa IU.

The drug is used to treat acute deep vein thrombosis and unstable coronary artery disease, as well as prevent postoperative thrombosis and clotting during hemodialysis and hemofiltration.

The pharmaceutical company's shares fell less than 2% during the midday trade.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590731377?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-10 12:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590731377","market":"sg","top_or_hot":-1,"title":"Dongcheng Pharmaceutical Subsidiary Gets Nod to Add New Specification for Dalteparin Sodium Injection","media":"MT Newswires Live","content":"<html><body><p> Yantai Dongcheng Pharmaceutical (SHE:002675) subsidiary, Yantai Dongcheng Northern Pharmaceutical, received approval from China's National Medical Products Administration to add a new specification for dalteparin sodium injection, according to a Shenzhen bourse filing on Wednesday.</p><p>The new specification to be marketed is 0.2 ml: 5000 AXa IU. The drug currently has a specification of 0.3 ml: 7500 AXa IU.</p><p>The drug is used to treat acute deep vein thrombosis and unstable coronary artery disease, as well as prevent postoperative thrombosis and clotting during hemodialysis and hemofiltration.</p><p>The pharmaceutical company's shares fell less than 2% during the midday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dongcheng Pharmaceutical Subsidiary Gets Nod to Add New Specification for Dalteparin Sodium Injection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDongcheng Pharmaceutical Subsidiary Gets Nod to Add New Specification for Dalteparin Sodium Injection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-10 12:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Yantai Dongcheng Pharmaceutical (SHE:002675) subsidiary, Yantai Dongcheng Northern Pharmaceutical, received approval from China's National Medical Products Administration to add a new specification for dalteparin sodium injection, according to a Shenzhen bourse filing on Wednesday.</p><p>The new specification to be marketed is 0.2 ml: 5000 AXa IU. The drug currently has a specification of 0.3 ml: 7500 AXa IU.</p><p>The drug is used to treat acute deep vein thrombosis and unstable coronary artery disease, as well as prevent postoperative thrombosis and clotting during hemodialysis and hemofiltration.</p><p>The pharmaceutical company's shares fell less than 2% during the midday trade.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"002675","symbol_name":"东诚药业","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2590731377","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590731377","pubTimestamp":1765340532,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Yantai Dongcheng Pharmaceutical  subsidiary, Yantai Dongcheng Northern Pharmaceutical, received approval from China's National Medical Products Administration to add a new specification for dalteparin sodium injection, according to a Shenzhen bourse filing on Wednesday.The new specification to be marketed is 0.2 ml: 5000 AXa IU. The drug currently has a specification of 0.3 ml: 7500 AXa IU.The drug is used to treat acute deep vein thrombosis and unstable coronary artery disease, as well as prevent postoperative thrombosis and clotting during hemodialysis and hemofiltration.The pharmaceutical company's shares fell less than 2% during the midday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"002675":"东诚药业","BK0239":"医药制造"},"translate_title":"东诚药业子公司达肝素钠注射液新增规格获Nod","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002675":0.9},"content_text":"Yantai Dongcheng Pharmaceutical (SHE:002675) subsidiary, Yantai Dongcheng Northern Pharmaceutical, received approval from China's National Medical Products Administration to add a new specification for dalteparin sodium injection, according to a Shenzhen bourse filing on Wednesday.The new specification to be marketed is 0.2 ml: 5000 AXa IU. The drug currently has a specification of 0.3 ml: 7500 AXa IU.The drug is used to treat acute deep vein thrombosis and unstable coronary artery disease, as well as prevent postoperative thrombosis and clotting during hemodialysis and hemofiltration.The pharmaceutical company's shares fell less than 2% during the midday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590731377","isCrawlerRequest":true}